Impact of COVID-19 on pregnant women with Rheumatic heart disease or Peripartum cardiomyopathy

Eur J Obstet Gynecol Reprod Biol. 2021 Mar:258:459-461. doi: 10.1016/j.ejogrb.2021.01.024. Epub 2021 Jan 18.
No abstract available

Publication types

  • Letter

MeSH terms

  • Abnormalities, Multiple
  • Adult
  • COVID-19 / complications
  • COVID-19 / physiopathology*
  • COVID-19 / therapy
  • Cardiomyopathies / complications
  • Cardiomyopathies / diagnostic imaging
  • Cardiomyopathies / drug therapy
  • Cardiomyopathies / physiopathology*
  • Echocardiography
  • Female
  • Fetal Membranes, Premature Rupture*
  • Humans
  • Infant, Low Birth Weight
  • Infant, Newborn
  • Perinatal Death
  • Pregnancy
  • Pregnancy Complications, Cardiovascular / diagnostic imaging
  • Pregnancy Complications, Cardiovascular / drug therapy
  • Pregnancy Complications, Cardiovascular / physiopathology*
  • Pregnancy Complications, Infectious / physiopathology*
  • Pregnancy Complications, Infectious / therapy
  • Premature Birth*
  • Rheumatic Heart Disease / complications
  • Rheumatic Heart Disease / diagnostic imaging
  • Rheumatic Heart Disease / drug therapy
  • Rheumatic Heart Disease / physiopathology*
  • Young Adult

Supplementary concepts

  • Preterm Premature Rupture of the Membranes